Systematic reviews and meta-analyses of random clinical trials show that GLP-1 receptor agonists, which are the drug versions of GLP-1 supplements, help people lose weight and control blood sugar levels involved in glucose regulation
Quebec has made their stance quite clear about how they view obesity
For gastrointestinal use, it is commonly discussed for gut irritation, gastritis-type symptoms, reflux-type irritation, inflammatory gut symptoms, and mucosal support
Diabetic neuropathy mainly comprises distal symmetric polyneuropathy, leading to sensory loss, pain, and motor dysfunction, and can result in diabetic foot ulcers requiring lower-limb amputations
The findings demonstrated for the first time that there is a GLP-1-brain-immune axis that controls inflammation across the body independent of weight loss, even in peripheral organs devoid of GLP1 receptors, said Dr